COVID-19
TOOLBOX
Filter
14
Featured
Language
Document type
Resource Platforms
6
Fact sheets
4
Infographics
2
Videos
2
Countries / Regions
Germany
6
Latin America and the Carribbean
1
Authors & Publishers
Robert-Koch-Institut RKI
3
World Health Organization WHO
3
Deutsches Grünes Kreuz e. V., Marburg, Robert Koch-Institut RKI
1
Harding-Zentrum für Risikokompetenz
1
Kamradt, T., and B.S. Kamps
1
Kamradt, T., B.S. Kamps J. García-Rosales Delgado
1
Mauder, S.
1
Mauder, S., K. Geffert
1
MEDBOX
1
New England Journal of Medicine
1
Pan American Health Organisation PAHO
1
Robert-Koch-Instiut RKI
1
Publication Years
Category
COVID-19
6
Information, Education and Communication (IEC)
3
x MEDBOX Issue Brief & Annual Reports x
2
Toolboxes
mRna Vaccines general
14
Vector-based Vacines General
8
Vaccine Candidates & Research
6
Research & Pipeline
6
Communication Material
5
COVID-19 Vaccination
5
Dashboards & Resource Platforms
5
COVID-19 Vaccination Information
5
Videos
4
Scientific & Research Studies
3
Access & Strategy
2
Immunization Guidelines
2
Vaccination
1
COVID-19 Information
1
For General Public & Community
1
For Migrants & Refugees
1
Country specific documents
1
For Older People
1
Vaccination & Strategy
1
Inactivated COVID-19 Vaccines
1
Pharmacovigilance
1
The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline. The COVID-19 vaccine tracker: Provides summary tables of COVID-19 vaccine candidates in both clinical and pre-... more
PhD Martin Moder, österreichischer Molekularbiologe, Autor populärwissenschaftlicher Bücher und Teil der Wissenschaftskabarettgruppe Science Busters, erklärt die Wirkweise und potentiellen Risiken der mRNA-Impfstoffe gegen COVID19

Impfung & COVID-19

Mauder, S., K. Geffert MEDBOX (2021) CC
MEDBOX Issue Brief no. 7, Dec. 2020 Die Impfung gegen die Ausbreitung des SARS-CoV-2-Virus stellt einen Meilenstein in der Bekämpfung der Pandemie dar. Für den Erfolg der Impfung unabdingbar ist eine gute Kommunikation und Aufklärung der Bevölkerung. Im Folgenden sind einige Informationen zur I... more
A collection of resources on Covid-19 vaccines, including frequently asked questions, continuing medical education, published research, and commentary.

Vaccines

COVID Reference 23 May 2021

COVID-19 & Vaccination

Mauder, S. (2021) CC
Issue Brief no.8. January 18,2021 Vaccination against the spread of the SARS-CoV-2 virus represents a milestone in the fight against the pandemic. Good communication and education of the population is essential for the success of the vaccination. Below is some information on vaccination strategies,... more
Februrar 2021
INFO Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019)–mit mRNA-Impfstoffen – Erklärung für die Formulare
Diese Faktenboxen sollen Ihnen helfen, Nutzen und Schaden einer Schutzimpfung gegen COVID-19 abzuwägen. Die Informationen und Zahlen stellen keine endgültige Bewertung dar. Sie basieren auf den derzeit besten wissenschaftlichen Erkenntnissen.
COVID Reference 23 May 2021
This chronology of facts has challenged public health systems worldwide and regulatory bodies are no exception. Regulatory authorities with mechanisms in place to authorize the use of investigational products had to development guidelines and procedures, create task forces and alliances to maximize ... more
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna Stand 21. Dezember 2021
mRNA technologies. What is their future and scope, and what are the challenges that countries might face in rolling them out? Hello and welcome to Science in5. I'm Vismita Gupta-Smith. We are talking to Dr.Soumya Swaminathan today. Soumya, talk to us about mRNA technologies. What is the future?